These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26614555)

  • 1. Novel biodegradable polymers for local growth factor delivery.
    Amsden B
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):318-28. PubMed ID: 26614555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor delivery: Defining the next generation platforms for tissue engineering.
    Caballero Aguilar LM; Silva SM; Moulton SE
    J Control Release; 2019 Jul; 306():40-58. PubMed ID: 31150750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
    Li J; Loh XJ
    Adv Drug Deliv Rev; 2008 Jun; 60(9):1000-17. PubMed ID: 18413280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current knowledge on biodegradable microspheres in drug delivery.
    Prajapati VD; Jani GK; Kapadia JR
    Expert Opin Drug Deliv; 2015 Aug; 12(8):1283-99. PubMed ID: 25687105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering growth factors for therapeutics.
    Anitua E; Sánchez M; Orive G; Andia I
    Trends Pharmacol Sci; 2008 Jan; 29(1):37-41. PubMed ID: 18037168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer carriers for drug delivery in tissue engineering.
    Sokolsky-Papkov M; Agashi K; Olaye A; Shakesheff K; Domb AJ
    Adv Drug Deliv Rev; 2007 May; 59(4-5):187-206. PubMed ID: 17540473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
    Hernán Pérez de la Ossa D; Gil-Alegre ME; Ligresti A; Aberturas Mdel R; Molpeceres J; Torres AI; Di Marzo V
    J Drug Target; 2013 Sep; 21(8):710-8. PubMed ID: 23773072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrices and scaffolds for protein delivery in tissue engineering.
    Tessmar JK; Göpferich AM
    Adv Drug Deliv Rev; 2007 May; 59(4-5):274-91. PubMed ID: 17544542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent trends in drug delivery systems using biomaterials].
    Kurisawa M; Yui N
    Nihon Rinsho; 1996 Jul; 54(7):2004-11. PubMed ID: 8741703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications.
    Pillay V; Tsai TS; Choonara YE; du Toit LC; Kumar P; Modi G; Naidoo D; Tomar LK; Tyagi C; Ndesendo VM
    J Biomed Mater Res A; 2014 Jun; 102(6):2039-54. PubMed ID: 23852673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in polymeric microspheres for parenteral drug delivery--part 1.
    Mao S; Guo C; Shi Y; Li LC
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1161-76. PubMed ID: 22835210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular polymers based on cyclodextrins for drug and gene delivery.
    Li JJ; Zhao F; Li J
    Adv Biochem Eng Biotechnol; 2011; 125():207-49. PubMed ID: 20839082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor delivery approaches in hydrogels.
    Silva AK; Richard C; Bessodes M; Scherman D; Merten OW
    Biomacromolecules; 2009 Jan; 10(1):9-18. PubMed ID: 19032110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM).
    Feng SS; Ruan G; Li QT
    Biomaterials; 2004 Sep; 25(21):5181-9. PubMed ID: 15109842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization challenges and formulation strategies associated with oral biologic drug delivery systems.
    Truong-Le V; Lovalenti PM; Abdul-Fattah AM
    Adv Drug Deliv Rev; 2015 Oct; 93():95-108. PubMed ID: 26277263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembling peptide-based delivery of therapeutics for myocardial infarction.
    Boopathy AV; Davis ME
    Methods Mol Biol; 2014; 1141():159-64. PubMed ID: 24567138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term delivery of protein therapeutics.
    Vaishya R; Khurana V; Patel S; Mitra AK
    Expert Opin Drug Deliv; 2015 Mar; 12(3):415-40. PubMed ID: 25251334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW; Tegnell E; Toporek SS; Reichert WM
    Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.